Trial Profile
Clinical Efficacy of Intravitreal Conbercept for the Treatment Macular Edema secondary to Branch Retinal Vein Occlusion
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 27 Sep 2016
Price :
$35
*
At a glance
- Drugs Conbercept (Primary) ; Ranibizumab
- Indications Branch retinal vein occlusion; Retinal oedema
- Focus Therapeutic Use
- 27 Sep 2016 New trial record